Studies on Left Ventricular Hypertrophy Regression in Arterial Hypertension: A Clear Message for the Clinician?
Author(s) -
Cesare Cuspidi,
Andrea Esposito,
Francesca Negri,
C. Sala,
M Masaidi,
Vittorio Giudici,
Alberto Zanchetti,
Giuseppe Mancia
Publication year - 2008
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1038/ajh.2007.85
Subject(s) - medicine , left ventricular hypertrophy , cardiology , blood pressure , continuous variable , randomized controlled trial , placebo , muscle hypertrophy , pathology , alternative medicine
Evidence-based medicine should provide clear and unbiased information to clinicians. We conducted an analysis on published randomized trials evaluating the effects of antihypertensive therapy on left ventricular (LV) morphology assessed by echocardiography to investigate (i) the consistency of criteria used for definition of LV hypertrophy (LVH) and (ii) the consistency of the way LVH regression and blood pressure (BP) control were reported.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom